Eden Research (LON:EDEN) Hits New 1-Year Low – Should You Sell?

Posted by Geri Gentry on Mar 21st, 2025

Eden Research plc (LON:EDEN – Get Free Report)’s share price hit a new 52-week low during mid-day trading on Wednesday . The company traded as low as GBX 2.90 ($0.04) and last traded at GBX 2.90 ($0.04), with a volume of 258375 shares changing hands. The stock had previously closed at GBX 2.95 ($0.04).

Eden Research Stock Performance

The stock’s 50-day moving average price is GBX 3.54 and its 200-day moving average price is GBX 3.79. The company has a market capitalization of £14.93 million, a price-to-earnings ratio of -9.81 and a beta of 0.92. The company has a debt-to-equity ratio of 1.26, a quick ratio of 2.42 and a current ratio of 3.80.

Insider Activity at Eden Research

In other Eden Research news, insider Alexander John Abrey purchased 167,947 shares of the stock in a transaction dated Tuesday, March 4th. The shares were acquired at an average cost of GBX 3 ($0.04) per share, for a total transaction of £5,038.41 ($6,533.21). Also, insider Lykele van der Broek acquired 256,000 shares of the company’s stock in a transaction dated Thursday, February 6th. The shares were acquired at an average cost of GBX 4 ($0.05) per share, with a total value of £10,240 ($13,278.01). Insiders bought 964,487 shares of company stock valued at $3,690,001 in the last ninety days. Corporate insiders own 14.02% of the company’s stock.

Eden Research Company Profile

(Get Free Report)

Eden Research is the only UK-listed company focused on biopesticides for sustainable agriculture. It develops and supplies innovative biopesticide products and natural microencapsulation technologies to the global crop protection, animal health and consumer products industries.

Eden’s products are formulated with terpene active ingredients, based on natural plant defence metabolites.